bf/NASDAQ:RYTM_icon.jpeg

COM:RHYTHMTX

Rhythm Pharmaceuticals

  • Stock

USD

Last Close

59.03

22/11 21:00

Market Cap

2.71B

Beta: -

Volume Today

302.44K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.46M
-
5.77M
295.65%
average payables
1.85M
-
1.66M
-
2.16M
30.06%
5.03M
132.92%
9.03M
79.35%
7.66M
15.18%
5.32M
30.55%
5.27M
0.97%
4.84M
8.09%
average receivables
512.50K
-
3.62M
607.22%
10.55M
190.95%
book value per share
-1.14
-
1.91
267.34%
0.44
77.20%
10.91
2,401.88%
7.94
27.22%
7.72
2.86%
3.77
51.09%
5.73
51.80%
5.07
11.50%
0.00
99.94%
capex per share
-0.00
-
-0.06
6,117.65%
-0.01
84.13%
-0.02
132.31%
-0.09
299.09%
-0.00
94.78%
-0.11
2,159.06%
-0.08
25.03%
-0.00
100.00%
capex to depreciation
-7.34
-
-0.60
91.87%
-1.63
173.88%
-4.06
148.47%
-0.31
92.36%
-4.69
1,413.03%
-2.56
45.44%
-0.03
98.96%
capex to operating cash flow
0.00
-
0.05
1,768.32%
0.00
90.08%
0.01
157.71%
0.03
137.02%
0.00
93.64%
0.04
2,021.45%
0.02
33.68%
0.00
98.60%
capex to revenue
-1.72
-
-0.18
89.49%
-0.00
99.66%
cash per share
0.35
-
2.08
489.87%
0.63
69.78%
11.16
1,672.00%
8.13
27.16%
8.03
1.23%
3.92
51.23%
5.94
51.81%
6.39
7.57%
0.00
99.93%
days of inventory on hand
499.16
-
338.40
32.21%
days payables outstanding
3.50K
-
820.86
76.52%
191.68
76.65%
days sales outstanding
118.62
-
96.11
18.98%
70.08
27.08%
debt to assets
0.10
-
0.01
-
0.02
43.04%
0.01
53.07%
0.01
34.35%
0.00
25.50%
debt to equity
0.11
-
0.01
-
0.02
46.37%
0.01
51.55%
0.01
18.06%
0.01
0.90%
dividend yield
earnings yield
-0.01
-
-0.02
55.25%
-0.05
133.65%
-0.09
69.60%
-0.09
1.65%
-0.16
81.14%
-0.10
38.10%
-0.14
37.87%
-0.12
12.20%
-0.00
99.94%
enterprise value
1.50B
-
467.02M
68.88%
495.34M
6.07%
351.33M
29.07%
783.85M
123.11%
777.52M
0.81%
1.21B
56.15%
438.31M
63.90%
1.39B
217.59%
2.65T
190,354.98%
enterprise value over ebitda
-70.03
-
-46.36
33.80%
-19.23
58.53%
-11.50
40.19%
-10.00
13.08%
-5.33
46.72%
-8.89
66.93%
-2.58
71.01%
-7.91
207.01%
-14.38K
181,636.84%
ev to operating cash flow
-78.34
-
-66.94
14.56%
-21.33
68.13%
-11.93
44.10%
-12.63
5.92%
-6.33
49.85%
-9.95
57.14%
-3.00
69.84%
-8.03
167.36%
-19.47K
242,489.26%
ev to sales
138.97
-
58.89
57.62%
34.24K
58,044.02%
free cash flow per share
-0.38
-
-0.42
9.71%
-1.45
247.10%
-2.23
53.71%
-2.02
9.22%
-3.46
71.03%
-2.77
20.04%
-3.05
10.26%
-3.41
11.67%
-0.00
99.93%
free cash flow yield
-0.01
-
-0.01
9.71%
-0.05
247.10%
-0.08
58.68%
-0.08
1.85%
-0.15
100.23%
-0.09
38.25%
-0.31
228.45%
-0.12
61.73%
-0.00
99.96%
graham net net
-1.15
-
1.77
253.63%
0.33
81.43%
10.64
3,138.49%
7.68
27.80%
7.27
5.28%
3.45
52.57%
5.05
46.23%
4.24
15.89%
0.00
99.95%
graham number
3.31
-
5.34
61.18%
3.90
27.01%
24.98
541.11%
20.66
17.27%
25.33
22.60%
15.86
37.39%
13.29
16.18%
20.02
50.58%
0.01
99.93%
income quality
0.89
-
0.63
29.51%
0.90
42.43%
0.87
2.62%
0.84
4.13%
0.87
4.10%
0.91
4.37%
2.10
130.40%
0.96
54.35%
0.74
23.00%
intangibles to total assets
0
-
0
0
0
0
0
0
0.01
Infinity%
0.02
45.80%
0.02
2.48%
interest coverage
-34.45
-
13.27
138.53%
interest debt per share
0.21
-
0.10
-
0.07
28.41%
0.05
26.46%
0.14
166.54%
-0.00
100.16%
inventory turnover
0.73
-
1.08
47.51%
invested capital
0.11
-
0.01
-
0.02
46.37%
0.01
51.55%
0.01
18.06%
0.01
0.90%
market cap
1.51B
-
501.88M
66.72%
501.88M
0%
385.57M
23.18%
833.39M
116.15%
836.26M
0.34%
1.31B
56.88%
495.01M
62.27%
1.52B
206.61%
2.65T
174,581.29%
net current asset value
-57.51M
-
30.22M
152.55%
6.13M
79.70%
143.72M
2,243.44%
244.74M
70.28%
274.90M
12.33%
161.12M
41.39%
263.01M
63.24%
236.02M
10.26%
145.28M
38.44%
net debt to ebitda
0.34
-
3.46
907.28%
0.25
92.67%
1.12
341.44%
0.63
43.63%
0.40
36.32%
0.72
77.94%
0.33
53.43%
0.71
114.38%
0.32
55.36%
net income per share
-0.43
-
-0.66
55.25%
-1.55
133.65%
-2.54
64.28%
-2.39
5.97%
-3.70
54.73%
-2.96
19.85%
-1.37
53.72%
-3.51
156.19%
-0.00
99.91%
operating cash flow per share
-0.38
-
-0.42
9.44%
-1.39
232.79%
-2.22
59.98%
-2.00
9.86%
-3.37
68.38%
-2.76
17.98%
-2.94
6.49%
-3.33
13.04%
-0.00
99.93%
payables turnover
0.10
-
0.44
325.87%
1.90
328.24%
receivables turnover
3.08
-
3.80
23.43%
5.21
37.13%
research and ddevelopement to revenue
33.01
-
4.60
86.08%
1.74
62.07%
return on tangible assets
-1.18
-
-0.30
74.79%
-2.10
605.83%
-0.22
89.40%
-0.28
28.12%
-0.44
53.30%
-0.70
60.15%
-0.21
70.04%
-0.49
133.47%
-0.57
16.01%
revenue per share
0.06
-
0.45
613.22%
0.00
99.70%
roe
0.37
-
-0.35
192.77%
-3.55
924.67%
-0.23
93.43%
-0.30
29.18%
-0.48
59.28%
-0.79
63.87%
-0.24
69.51%
-0.69
189.47%
-1.09
57.03%
roic
0.37
-
-0.30
179.67%
-3.55
1,093.79%
-0.23
93.49%
-0.34
45.96%
-0.48
43.77%
-0.77
59.17%
-0.57
25.55%
-0.68
17.58%
-1.07
58.94%
sales general and administrative to revenue
shareholders equity per share
-1.14
-
1.91
267.34%
0.44
77.20%
10.91
2,401.88%
7.94
27.22%
7.72
2.86%
3.77
51.09%
5.73
51.80%
5.07
11.50%
0.00
99.94%
stock based compensation to revenue
6.60
-
0.84
87.28%
0.42
49.89%
tangible asset value
-57.46M
-
32.00M
155.69%
7.30M
77.20%
144.79M
1,884.21%
246.26M
70.08%
281.02M
14.12%
166.53M
40.74%
279.49M
67.84%
256.38M
8.27%
162.73M
36.53%
tangible book value per share
-1.14
-
1.91
267.34%
0.44
77.20%
10.91
2,401.88%
7.94
27.22%
7.72
2.86%
3.77
51.09%
5.63
49.32%
4.92
12.71%
0.00
99.94%
working capital
15.08M
-
30.22M
100.40%
6.44M
78.67%
143.95M
2,133.88%
245.11M
70.27%
277.99M
13.41%
163.67M
41.12%
264.96M
61.88%
314.43M
18.67%
253.06M
19.52%

All numbers in USD (except ratios and percentages)